TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ELAN

Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.70$ -0.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Elanco Animal Health (ELAN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,715 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ELAN
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2,909 2,914 2,889 3,067 3,071 3,273 4,764 4,411 4,417 4,439 4,715
1,697 1,580 1,715 1,771 1,671 2,027 2,688 2,441 2,479 2,530 2,665
1,212 1,334 1,174 1,296 1,400 1,247 2,076 1,970 1,938 1,909 2,050
291 266 252 247 270 327 369 321 327 344 368
916 785 780 735 760 997 1,156 1,065 1,073 1,078 1,430
1,207 1,051 1,032 982 1,030 1,324 1,772 1,586 1,612 1,658 1,798
5.4 283 142 314 370 -77 304 384 326 251 252
0.0 0.0 0.0 30 79 156 264 256 277 339 220
-260 -22 -233 114 78 -672 -571 -72 -1,195 488 -224
-49 26 78 28 10 -112 -88 6.0 36 150 8.0
-211 -48 -311 87 68 -560 -483 -78 -1,231 338 -232
-23 232 86 440 472 0.9 409 866 -224 1,489 676

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?